It’s a Trap! Why Schedule III Could Be Worse Than Standing Still on Cannabis Reform
“The only clearly understood consequence of moving cannabis to Schedule III is ending the unfair, excessive tax burden, providing a financial benefit for all marijuana companies and a windfall for the largest ones. The rosy prospect of this windfall is fueling dangerous myths: that rescheduling would legalize state cannabis programs, make research easier, or lead […]
Fentanyl Bill Signed By Trump Would Also ‘Streamline Research’ On Schedule I Drugs Like Marijuana, Congressional Analysts Say
A bill signed into law by President Donald Trump last month banning fentanyl analogues would also make a series of changes to current laws that have restricted research into Schedule I drugs like marijuana and psychedelics, congressional analysts say. In a report published last week—shortly after Trump gave final approval to the Halt All Lethal […]